Carbon Dot-Based Nanoparticles: A Promising Therapeutic Approach for Glioblastoma
International Journal of Nanomedicine · 2025
DOI: 10.2147/ijn.s519733 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Yongzhi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Fu Yang People's Hospital, FuYang, People's Republic of China. Hauptthemen laut MEDLINE: Glioblastoma, Carbon, Quantum Dots, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Fu Yang People's Hospital, FuYang, People's Republic of China.
- Department of Neurosurgery,The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
- Department of Neurosurgery, The Second Affiliated Hospital of Xi'an Medical University, Xi'an, People's Republic of China.
- Department of Neurosurgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, People's Republic of China.
ORCID-Profile: Hao Wu, Yu Guo, Hengzhu Zhang
Zitieren
APA
Wang, Y., Wu, H., Guo, Y., Li, F., & Zhang, H. (2025). Carbon Dot-Based Nanoparticles: A Promising Therapeutic Approach for Glioblastoma. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s519733
Vancouver
Wang Y, Wu H, Guo Y, Li F, Zhang H. Carbon Dot-Based Nanoparticles: A Promising Therapeutic Approach for Glioblastoma. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s519733
BibTeX
@article{Wang2025,
author = {Wang, Yongzhi and Wu, Hao and Guo, Yu and Li, Fangbao and Zhang, Hengzhu},
title = {Carbon Dot-Based Nanoparticles: A Promising Therapeutic Approach for Glioblastoma},
journal = {International Journal of Nanomedicine},
year = {2025},
doi = {10.2147/ijn.s519733}
}
EUVIMED